Contact Us

  • You can also contact Embody directly at 757-777-5674. Media inquiries should be emailed to media@embody-inc.com
Contact Us

Science

Our Technology

Repair. Regenerate. Restore.

The importance of collagen is well understood within the medical industry. Collagen-based regenerative matrices have been widely used in applications such as drug and other biologics delivery and wound healing. However, for soft tissue repair, the historical challenge of collagen-based implants has been creating a graft with sufficient biological and mechanical performance. Embody is leveraging our creative chemistries and improving upon two separate advanced additive manufacturing platforms, electrospinning and microfluidic extrusion, to address these prior limitations.

Technology Platforms

BIOSPIN®

Microfibrous collagen bioengineered implant for soft tissue augmentation with biomechanical performance

BIOSPIN, a hybrid electrospinning / pneumatospinning medical device manufacturing process that produces highly organized, highly porous collagen-based microfibrous implants designed for soft tissue augmentation.  The BIOSPIN platform technology is used in our TAPESTRY® Biointegrative Implant for tendon and ligament repair.

FABRITEC®

Microfluidic biofabrication to precisely control molecular assembly of collagen microfibers

FABRITEC, a high-output microfluidic wet-extrusion process that assembles clinical-grade collagen from the molecular- through product-scale, combined with a proprietary natural crosslinking chemistry, to produce high-strength pure collagen microfibers.  The microfibers generated can be further manufactured into biological textiles, as found in our MICROBRAID and MICROBRACE® products.

Our PRODUCTS


TAPESTRY Biointegrative Implant is the first collagen-based implant with a bioengineered micro-architecture and bio-stimulative, highly organized Type I collagen chemistry specifically designed for tendon repair. TAPESTRY’s proprietary physio-chemistry demonstrated dense collagenous tissue in-growth.

 Learn more about Embody’s first FDA cleared product, TAPESTRY.


TAPESTRY RCR* incorporates the TAPESTRY Biointegrative Implant with a novel delivery and fixation system for the augmentation of partial to full tear rotator cuff repairs via 510(k) pathway in 2021.



MICROBRAID* high-strength, collagen orthopedic suture line capitalizing on the strength and remodeling enabled by our FABRITEC technology.


MICROBRACE* leverages a collagen orthopedic suture with a full implant and instrument solution for extra-articular applications.

 

* This product is not cleared by the USFDA for commercial distribution of sale in the United States.